drugset / Trial / NCT02286973

Combined Administration of Intravenous and Topical Tranexamic Acid in Total Knee Arthroplasty

NCT02286973

Phase 1 Unknown 264 enrolled Seoul National University Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

This prospective randomized controlled trial was conducted To compare the efficacy of TNA in terms of total blood loss and the allogenic transfusion rate among the three study groups; intravenous alone, combined intravenous and low dose topical TNA and combined intravenous and high dose topical TNA. To evaluate the safety of each regimen in view of deep vein thrombosis and venous thromboembolism.

Timeline

Start
2014-11
Primary completion
2015-04
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 10 unknown Intravenous
Comparator Tranexamic Acid Small molecule 1 g Intravenous
Comparator Tranexamic Acid Small molecule 2 g Intravenous

Indications